🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

2 abstracts has been accepted for #USCAP2025! Looking forward to discussing more and more breast pathology in Boston🫶🏻 Brigham and Women's Pathology Dana-Farber’s Breast Oncology Center

There is nothing like a New England fall. Best hike ever @ Mount Major 🍂🍁

I am SUPER EXCITED to see Dr. E Mittendorf as ASCO president-elect. She is an amazing breast surgeon, scientist, colleague, friend, and leader! This is wonderful for ASCO! Dana-Farber’s Breast Oncology Center

So excited to see friend and colleague Dr. E Mittendorf nominated for president elect of ASCO -a shining star for the future of equitable, high quality multi-disciplinary cancer care, research and education. Cast your vote ! BWH Surgical Oncology Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center

Thanks to @AnnieMcLeanDMD and Peter Sadow, MD, PhD at Head Neck Pathol for giving us the chance to publish on "Choosing a fellowship" (information works for pathology in general) Karleen Meiklejohn, MD 💀💉🔬 and I hope it will be useful! rdcu.be/dZHsg #pathology #MedEd #pathtwitter

The “Flying Microtonal Banana” is a heavily Turkish Anatolian rock-influenced album with incredibly clever use of zurna. KGLW did an amazing job there. It’s worth checking out if you haven’t already.

🛎️Hot off the press 👉Estrogen signaling in early-stage #BreastCancer: Impact on neoadjuvant chemotherapy and immunotherapy. Read the full text here: 🔓doi.org/10.1016/j.ctrv… ✍️Chiara Corti Busem Binboga Kurt Giampaolo Bianchini Carmen Criscitiello G Curigliano MD PhD Sheheryar Kabraji Ada Waks Dr. E Mittendorf

I am truly grateful for the opportunity to bring together with this paper the amazing people I have had the privilege of working with in the field of #immunotherapy. #bcsm #breastcancer #OpenAccess cancertreatmentreviews.com/article/S0305-…

Lifetime Cancer Risk Associated with High- and Moderate-Penetrance Mutations in Selected Genes #hereditarycancer

What an incredible leader, mentor, and inspiration 🤩 Many deeply heartfelt congratulations!!! Dr. E Mittendorf ASCO

A beauty on a snowy Boston morning 🌨️❄️

Now published in Clinical Cancer Research! HER2 loss in not infrequent after treatment with T-DXd. Almost one third of treated patients had complete loss and an additional one third had decrease in HER2 IHC score! 𝗟𝗶𝗻𝗸 𝘁𝗼 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: aacrjournals.org/clincancerres/…

Stumbled upon Bill Evans’s notes for Kind of Blue in New York Public Library, wow

I am super excited for match day, it is a different kind of energy this year for me. I am looking forward to meeting our future friends in Mass General Brigham Pathology 🫶🏻🥳🥳 #Match2025 #pathmatch2025

We couldn’t be more thrilled to introduce this stellar new class of 19 (yes, 19!) PGY1s joining the Mass General Brigham pathology family! 🥳 Welcome to the team — we can’t wait to have you on board and see you thrive! 🧬🔬💫

Seeing this example of an old report format of breast cancer during legendary Dr. Ellis’s talk made me appreciate more how far we have come and how the future is as exciting and promising for our patients #USCAP2025 #breastcancer

Great to stop by #USCAP25 this afternoon to support our team’s work using #MachineLearning to characterize the tumor microenvironment in post-surgical #TNBC specimens after neoadjuvant chemo. Beyza Koca Busem Binboga Kurt DFCI BOC Translational Hub USCAP

🚨 New paper alert! 🚨 ✏ Authors: Soma Jobbagy, Emilio Madrigal, DO , Rosalynn Nazarian MD, Kristine M Cornejo MD, Mia DeSimone, Alvaro C. Laga, Anna Stagner, et al! 🔗 Read here: laboratoryinvestigation.org/article/S0023-… #DermPath #PathTwitter

🚨NEW ASCO #EduBook chapter: Hope Rugo, Sara Tolaney, and I unpack some of the most debated trial design issues in m+ #BreastCancer—suboptimal control arms, crossover challenges, post-progression tx, non-inferiority margins, patient selection, and more. ➡️ shorturl.at/nZWdI

Something for the road (my 45-minute Green Line ride to MGH) 🥰 #boston #PathTwitter